Page last updated: 2024-08-17

lysine and Peripheral Arterial Disease

lysine has been researched along with Peripheral Arterial Disease in 3 studies

Research

Studies (3)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's3 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Barzilay, J; Biggs, ML; Djousse, L; Garg, PK; Hirsch, C; Ix, JH; Kizer, JR; Mukamal, KJ; Newman, AB; Siscovick, DS; Tracy, RP1
Brismar, K; Kärvestedt, L; Malmstedt, J; Swedenborg, J1
Frebelius, S; Jörneskog, G; Lengquist, M; Malmstedt, J; Swedenborg, J; Wang, J1

Other Studies

3 other study(ies) available for lysine and Peripheral Arterial Disease

ArticleYear
Advanced glycation end product carboxymethyl-lysine and risk of incident peripheral artery disease in older adults: The Cardiovascular Health Study.
    Diabetes & vascular disease research, 2019, Volume: 16, Issue:5

    Topics: Aged; Biomarkers; Female; Glycation End Products, Advanced; Humans; Incidence; Lysine; Male; Peripheral Arterial Disease; Prognosis; Risk Assessment; Risk Factors; Time Factors; United States

2019
The receptor for advanced glycation end products and risk of peripheral arterial disease, amputation or death in type 2 diabetes: a population-based cohort study.
    Cardiovascular diabetology, 2015, Jul-28, Volume: 14

    Topics: Aged; Amputation, Surgical; Biomarkers; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Disease Progression; Disease-Free Survival; Female; Humans; Incidence; Kaplan-Meier Estimate; Lysine; Male; Middle Aged; Peripheral Arterial Disease; Proportional Hazards Models; Receptor for Advanced Glycation End Products; Risk Assessment; Risk Factors; S100A12 Protein; Sweden; Time Factors

2015
The Receptor for Advanced Glycation End Products (Rage) and Its Ligands in Plasma and Infrainguinal Bypass Vein.
    European journal of vascular and endovascular surgery : the official journal of the European Society for Vascular Surgery, 2016, Volume: 51, Issue:4

    Topics: Adult; Aged; Amputation, Surgical; Biomarkers; Diabetic Angiopathies; Disease-Free Survival; Female; Glycation End Products, Advanced; Humans; Kaplan-Meier Estimate; Ligands; Lysine; Male; Middle Aged; Peripheral Arterial Disease; Proportional Hazards Models; Prospective Studies; Receptor for Advanced Glycation End Products; Reoperation; Risk Factors; S100A12 Protein; Time Factors; Treatment Outcome; Up-Regulation; Vascular Grafting; Veins

2016